CA2212093A1 - Medicament form for the delivery of active substances to wounds - Google Patents

Medicament form for the delivery of active substances to wounds

Info

Publication number
CA2212093A1
CA2212093A1 CA002212093A CA2212093A CA2212093A1 CA 2212093 A1 CA2212093 A1 CA 2212093A1 CA 002212093 A CA002212093 A CA 002212093A CA 2212093 A CA2212093 A CA 2212093A CA 2212093 A1 CA2212093 A1 CA 2212093A1
Authority
CA
Canada
Prior art keywords
wounds
delivery
active substances
medicament form
area
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002212093A
Other languages
French (fr)
Other versions
CA2212093C (en
Inventor
Michael Roreger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LTS Lohmann Therapie Systeme AG
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19503336A external-priority patent/DE19503336C2/en
Application filed by Individual filed Critical Individual
Publication of CA2212093A1 publication Critical patent/CA2212093A1/en
Application granted granted Critical
Publication of CA2212093C publication Critical patent/CA2212093C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/38—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Materials Engineering (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Preparation (AREA)

Abstract

A pharmaceutical form for delivery of active substances to wounds is characterized in that this is designed to be coherent, sheet-like and, in its extent in terms of area, equal to or smaller than the wound area to be managed, and contains active substance in a defined amount in homogeneously dispersed form.
CA002212093A 1995-02-02 1996-01-25 Medicament form for the delivery of active substances to wounds Expired - Fee Related CA2212093C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19503336.1 1995-02-02
DE19503336A DE19503336C2 (en) 1995-02-02 1995-02-02 Pharmaceutical form for delivering active substances to wounds, process for their preparation and their use
PCT/EP1996/000295 WO1996023488A1 (en) 1995-02-02 1996-01-25 Medicament form for the delivery of active substances to wounds

Publications (2)

Publication Number Publication Date
CA2212093A1 true CA2212093A1 (en) 1996-08-08
CA2212093C CA2212093C (en) 2007-05-22

Family

ID=38156707

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002212093A Expired - Fee Related CA2212093C (en) 1995-02-02 1996-01-25 Medicament form for the delivery of active substances to wounds

Country Status (1)

Country Link
CA (1) CA2212093C (en)

Also Published As

Publication number Publication date
CA2212093C (en) 2007-05-22

Similar Documents

Publication Publication Date Title
GR3033301T3 (en) Medicament form for the delivery of active substances to wounds
CA2132369A1 (en) Use for the Treatment of Mixed Skins, of an Effective Quantity of Active Substances
CA2416383A1 (en) Solution-, dispersion- or emulsion-producing film dermatics
CA2193337A1 (en) 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol compounds as pharmaceutical active ingredients
AU632539B2 (en) Pharmaceutical compositions useful as drug delivery vehicles and/or as wound dressings
CA2193481A1 (en) Colonic drug delivery composition
ATE201989T1 (en) MEDICINAL PRODUCTS WITH CONTROLLED DELIVERY OF ACTIVE INGREDIENTS
WO2000033820A3 (en) Nanoparticulate core-shell systems and use thereof in pharmaceutical and cosmetic preparations
EP0973507A4 (en) Dosage form exhibiting rapid disperse properties, methods of use and process for the manufacture of same
AU4709989A (en) Cosmetic or pharmaceutical composition containing microspheres of polymers or of fatty substances filled with at least one active product
AU4718496A (en) Use of aerogels in agriculture
WO1996041623A3 (en) Tricot-like pouch for the delivery of topical drugs and cosmetics
CA2031817A1 (en) Use of thrombospondin to promote wound healing
AU1671799A (en) Medicament preparation in the form of a tablet or pellet for acid-labile active substances
RU98122669A (en) ANTIVAGINITIC COMPOSITION FOR LOCAL USE, INCLUDING ONE OR MORE ANTIVAGINITIC MEDICINES AND ONE OR MORE LOCAL ANESTHETICS
DE69716460D1 (en) Wound healing and treatment of fibrosis
CA2247198A1 (en) Topical pharmaceutical composition containing heparin
CA2317443A1 (en) Agent for treating allergic or hypersensitivity condition
CA2212093A1 (en) Medicament form for the delivery of active substances to wounds
DE69616783T2 (en) OSMOTIC DEVICE WITH A HIGH CONTENT OF ACTIVE SUBSTANCES AND DELAYED ACTIVATION OF THE ACTIVE SUBSTANCE RELEASE
AU3266197A (en) Transdermic systems containing 2 active ingredients in separate compartments, their preparation process and their use as medicaments
AU4314993A (en) Mixtures of active anti-microbial substances
DE59607949D1 (en) SOLID MEDICINAL FORM WITH POLYMER MATERIAL DISTRIBUTED ACTIVE SUBSTANCE
TR199901237T2 (en) A new therapeutic application of a thienylcyclohexylamine derivative.
AU3039789A (en) Active substance for treating changes in the skin and mucous membranes

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20130125